Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
101 (47%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Actual shortage | 2025-01-09 | 2025-05-08 | 247316 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Actual shortage | 2025-02-20 | 2025-05-02 | 250900 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2023-06-20 | 2023-06-27 | 195861 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2019-10-17 | 2020-05-21 | 96724 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2019-06-18 | 2019-08-06 | 86933 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2019-06-18 | 2020-05-01 | 86936 |
| TEVA-PREDNISOLONE | 1% | SUSPENSION | Resolved | 2022-12-15 | 2023-06-09 | 178527 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2023-06-26 | 2023-07-21 | 196448 |
| TEVA-PREDNISONE | 5MG | TABLET | Resolved | 2022-12-01 | 2023-01-19 | 176761 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176764 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2025-02-13 | 2025-02-28 | 250387 |
| TEVA-PREDNISONE | 5MG | TABLET | Resolved | 2023-12-14 | 2024-02-15 | 213365 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2021-01-28 | 2021-03-04 | 132663 |
| TEVA-PREDNISONE | 5MG | TABLET | Resolved | 2020-04-03 | 2020-05-21 | 110770 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2020-04-03 | 2020-05-21 | 110773 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Resolved | 2020-03-26 | 2020-07-10 | 109638 |
| TEVA-PREGABALIN | 225MG | CAPSULE | Resolved | 2020-04-03 | 2020-05-08 | 110767 |
| TEVA-PREGABALIN | 150MG | CAPSULE | Resolved | 2020-04-10 | 2020-04-23 | 111854 |
| TEVA-PREGABALIN | 225MG | CAPSULE | Resolved | 2021-12-17 | 2021-12-23 | 151459 |
| TEVA-PREGABALIN | 25MG | CAPSULE | Resolved | 2022-01-20 | 2022-04-01 | 153183 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Discontinued | 2025-10-22 | 2025-10-22 | 257579 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 |